Use of botulinum toxin in Frey's syndrome

Frey's syndrome is the most common adverse event after parotidectomy, and usually, it appears after 6 months. In our case, symptoms appear 20 years from surgery, an uncommon condition. Intralesional botulinum toxin gives excellent results in therapy, regardless of the time elapsed between surge...

Descripción completa

Detalles Bibliográficos
Autores principales: Freni, Francesco, Gazia, Francesco, Stagno d’Alcontres, Ferdinando, Galletti, Bruno, Galletti, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406149/
https://www.ncbi.nlm.nih.gov/pubmed/30899477
http://dx.doi.org/10.1002/ccr3.2019
_version_ 1783401234806341632
author Freni, Francesco
Gazia, Francesco
Stagno d’Alcontres, Ferdinando
Galletti, Bruno
Galletti, Francesco
author_facet Freni, Francesco
Gazia, Francesco
Stagno d’Alcontres, Ferdinando
Galletti, Bruno
Galletti, Francesco
author_sort Freni, Francesco
collection PubMed
description Frey's syndrome is the most common adverse event after parotidectomy, and usually, it appears after 6 months. In our case, symptoms appear 20 years from surgery, an uncommon condition. Intralesional botulinum toxin gives excellent results in therapy, regardless of the time elapsed between surgery and the first treatment.
format Online
Article
Text
id pubmed-6406149
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64061492019-03-21 Use of botulinum toxin in Frey's syndrome Freni, Francesco Gazia, Francesco Stagno d’Alcontres, Ferdinando Galletti, Bruno Galletti, Francesco Clin Case Rep Case Reports Frey's syndrome is the most common adverse event after parotidectomy, and usually, it appears after 6 months. In our case, symptoms appear 20 years from surgery, an uncommon condition. Intralesional botulinum toxin gives excellent results in therapy, regardless of the time elapsed between surgery and the first treatment. John Wiley and Sons Inc. 2019-01-31 /pmc/articles/PMC6406149/ /pubmed/30899477 http://dx.doi.org/10.1002/ccr3.2019 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Freni, Francesco
Gazia, Francesco
Stagno d’Alcontres, Ferdinando
Galletti, Bruno
Galletti, Francesco
Use of botulinum toxin in Frey's syndrome
title Use of botulinum toxin in Frey's syndrome
title_full Use of botulinum toxin in Frey's syndrome
title_fullStr Use of botulinum toxin in Frey's syndrome
title_full_unstemmed Use of botulinum toxin in Frey's syndrome
title_short Use of botulinum toxin in Frey's syndrome
title_sort use of botulinum toxin in frey's syndrome
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406149/
https://www.ncbi.nlm.nih.gov/pubmed/30899477
http://dx.doi.org/10.1002/ccr3.2019
work_keys_str_mv AT frenifrancesco useofbotulinumtoxininfreyssyndrome
AT gaziafrancesco useofbotulinumtoxininfreyssyndrome
AT stagnodalcontresferdinando useofbotulinumtoxininfreyssyndrome
AT gallettibruno useofbotulinumtoxininfreyssyndrome
AT gallettifrancesco useofbotulinumtoxininfreyssyndrome

Ejemplares similares